GO:0000775 | chromosome, centromeric region | 1.87e-04 | 1.00e+00 | 4.726 | 3 | 6 | 41 |
GO:0006406 | mRNA export from nucleus | 2.32e-04 | 1.00e+00 | 4.624 | 3 | 7 | 44 |
GO:0006379 | mRNA cleavage | 2.62e-04 | 1.00e+00 | 6.329 | 2 | 2 | 9 |
GO:0005654 | nucleoplasm | 3.83e-04 | 1.00e+00 | 1.894 | 9 | 68 | 876 |
GO:0003723 | RNA binding | 5.09e-04 | 1.00e+00 | 2.872 | 5 | 22 | 247 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.36e-03 | 1.00e+00 | 5.177 | 2 | 2 | 20 |
GO:0030529 | ribonucleoprotein complex | 1.44e-03 | 1.00e+00 | 3.726 | 3 | 5 | 82 |
GO:0004832 | valine-tRNA ligase activity | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 1 |
GO:0052565 | response to defense-related host nitric oxide production | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 1 |
GO:0007066 | female meiosis sister chromatid cohesion | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 1 |
GO:0000939 | condensed chromosome inner kinetochore | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 2.76e-03 | 1.00e+00 | 8.499 | 1 | 1 | 1 |
GO:0031124 | mRNA 3'-end processing | 4.14e-03 | 1.00e+00 | 4.369 | 2 | 4 | 35 |
GO:0006369 | termination of RNA polymerase II transcription | 4.87e-03 | 1.00e+00 | 4.251 | 2 | 5 | 38 |
GO:0000398 | mRNA splicing, via spliceosome | 5.11e-03 | 1.00e+00 | 3.083 | 3 | 15 | 128 |
GO:0033065 | Rad51C-XRCC3 complex | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 2 |
GO:0048742 | regulation of skeletal muscle fiber development | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 2 |
GO:0048476 | Holliday junction resolvase complex | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 2 |
GO:0008074 | guanylate cyclase complex, soluble | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 2 |
GO:0003747 | translation release factor activity | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 2 | 2 |
GO:0004647 | phosphoserine phosphatase activity | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 2 |
GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 2 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 2 | 3 |
GO:0036123 | histone H3-K9 dimethylation | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 3 |
GO:0000778 | condensed nuclear chromosome kinetochore | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 2 | 3 |
GO:0006563 | L-serine metabolic process | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 8.27e-03 | 1.00e+00 | 6.914 | 1 | 1 | 3 |
GO:0006334 | nucleosome assembly | 8.64e-03 | 1.00e+00 | 3.826 | 2 | 4 | 51 |
GO:0008380 | RNA splicing | 1.03e-02 | 1.00e+00 | 2.717 | 3 | 21 | 165 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 4 |
GO:0097452 | GAIT complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 4 |
GO:0030828 | positive regulation of cGMP biosynthetic process | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 4 |
GO:0008821 | crossover junction endodeoxyribonuclease activity | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 4 |
GO:0007000 | nucleolus organization | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 4 |
GO:0006333 | chromatin assembly or disassembly | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 4 |
GO:0006564 | L-serine biosynthetic process | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 4 |
GO:0060087 | relaxation of vascular smooth muscle | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 1 | 5 |
GO:0004521 | endoribonuclease activity | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 1 | 5 |
GO:0006398 | histone mRNA 3'-end processing | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 2 | 5 |
GO:0006282 | regulation of DNA repair | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 1 | 5 |
GO:0071204 | histone pre-mRNA 3'end processing complex | 1.38e-02 | 1.00e+00 | 6.177 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 6 |
GO:0004383 | guanylate cyclase activity | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 6 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 6 |
GO:0005525 | GTP binding | 1.66e-02 | 1.00e+00 | 2.461 | 3 | 12 | 197 |
GO:0001649 | osteoblast differentiation | 1.76e-02 | 1.00e+00 | 3.289 | 2 | 5 | 74 |
GO:0002199 | zona pellucida receptor complex | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 4 | 7 |
GO:0007140 | male meiosis | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 2 | 7 |
GO:0008409 | 5'-3' exonuclease activity | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 7 |
GO:0042340 | keratan sulfate catabolic process | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 7 |
GO:0000400 | four-way junction DNA binding | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 3 | 7 |
GO:0000780 | condensed nuclear chromosome, centromeric region | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 4 | 7 |
GO:0051382 | kinetochore assembly | 1.92e-02 | 1.00e+00 | 5.691 | 1 | 2 | 7 |
GO:0005845 | mRNA cap binding complex | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 4 | 8 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.23e-02 | 1.00e+00 | 3.106 | 2 | 5 | 84 |
GO:0010225 | response to UV-C | 2.46e-02 | 1.00e+00 | 5.329 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 2.46e-02 | 1.00e+00 | 5.329 | 1 | 1 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 2.46e-02 | 1.00e+00 | 5.329 | 1 | 2 | 9 |
GO:0007062 | sister chromatid cohesion | 2.46e-02 | 1.00e+00 | 5.329 | 1 | 1 | 9 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 2.46e-02 | 1.00e+00 | 5.329 | 1 | 3 | 9 |
GO:0007141 | male meiosis I | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 10 |
GO:0005095 | GTPase inhibitor activity | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 10 |
GO:0006182 | cGMP biosynthetic process | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 10 |
GO:0008143 | poly(A) binding | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 10 |
GO:0018146 | keratan sulfate biosynthetic process | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 10 |
GO:0016032 | viral process | 2.87e-02 | 1.00e+00 | 1.757 | 4 | 30 | 428 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 3.00e-02 | 1.00e+00 | 5.039 | 1 | 4 | 11 |
GO:0006479 | protein methylation | 3.00e-02 | 1.00e+00 | 5.039 | 1 | 2 | 11 |
GO:0008652 | cellular amino acid biosynthetic process | 3.00e-02 | 1.00e+00 | 5.039 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 3.00e-02 | 1.00e+00 | 5.039 | 1 | 1 | 11 |
GO:0005739 | mitochondrion | 3.22e-02 | 1.00e+00 | 1.456 | 5 | 32 | 659 |
GO:0000132 | establishment of mitotic spindle orientation | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 2 | 12 |
GO:0007263 | nitric oxide mediated signal transduction | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 1 | 12 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 1 | 12 |
GO:0042339 | keratan sulfate metabolic process | 3.54e-02 | 1.00e+00 | 4.798 | 1 | 1 | 13 |
GO:0016746 | transferase activity, transferring acyl groups | 3.80e-02 | 1.00e+00 | 4.691 | 1 | 2 | 14 |
GO:0016575 | histone deacetylation | 3.80e-02 | 1.00e+00 | 4.691 | 1 | 2 | 14 |
GO:0007049 | cell cycle | 3.99e-02 | 1.00e+00 | 2.653 | 2 | 8 | 115 |
GO:0008135 | translation factor activity, nucleic acid binding | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 4 | 15 |
GO:0003887 | DNA-directed DNA polymerase activity | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 2 | 16 |
GO:0005657 | replication fork | 4.34e-02 | 1.00e+00 | 4.499 | 1 | 3 | 16 |
GO:0005640 | nuclear outer membrane | 4.60e-02 | 1.00e+00 | 4.411 | 1 | 1 | 17 |
GO:0007131 | reciprocal meiotic recombination | 4.60e-02 | 1.00e+00 | 4.411 | 1 | 1 | 17 |
GO:0031667 | response to nutrient levels | 4.60e-02 | 1.00e+00 | 4.411 | 1 | 2 | 17 |
GO:0031047 | gene silencing by RNA | 4.87e-02 | 1.00e+00 | 4.329 | 1 | 2 | 18 |
GO:0006378 | mRNA polyadenylation | 4.87e-02 | 1.00e+00 | 4.329 | 1 | 3 | 18 |
GO:0033574 | response to testosterone | 4.87e-02 | 1.00e+00 | 4.329 | 1 | 1 | 18 |
GO:0006913 | nucleocytoplasmic transport | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 20 |
GO:0046966 | thyroid hormone receptor binding | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 3 | 20 |
GO:0071346 | cellular response to interferon-gamma | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 20 |
GO:0005720 | nuclear heterochromatin | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 3 | 20 |
GO:0071897 | DNA biosynthetic process | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 5.39e-02 | 1.00e+00 | 4.177 | 1 | 1 | 20 |
GO:0000278 | mitotic cell cycle | 5.45e-02 | 1.00e+00 | 1.789 | 3 | 28 | 314 |
GO:0007569 | cell aging | 5.65e-02 | 1.00e+00 | 4.106 | 1 | 1 | 21 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 5.65e-02 | 1.00e+00 | 4.106 | 1 | 2 | 21 |
GO:0010467 | gene expression | 5.75e-02 | 1.00e+00 | 1.435 | 4 | 49 | 535 |
GO:0051084 | 'de novo' posttranslational protein folding | 5.92e-02 | 1.00e+00 | 4.039 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 5.92e-02 | 1.00e+00 | 4.039 | 1 | 1 | 22 |
GO:0005622 | intracellular | 6.04e-02 | 1.00e+00 | 2.319 | 2 | 2 | 145 |
GO:0006370 | 7-methylguanosine mRNA capping | 6.44e-02 | 1.00e+00 | 3.914 | 1 | 5 | 24 |
GO:0008180 | COP9 signalosome | 6.44e-02 | 1.00e+00 | 3.914 | 1 | 6 | 24 |
GO:0044822 | poly(A) RNA binding | 6.48e-02 | 1.00e+00 | 1.178 | 5 | 45 | 799 |
GO:0010827 | regulation of glucose transport | 6.70e-02 | 1.00e+00 | 3.855 | 1 | 7 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 6.70e-02 | 1.00e+00 | 3.855 | 1 | 3 | 25 |
GO:0009267 | cellular response to starvation | 6.95e-02 | 1.00e+00 | 3.798 | 1 | 1 | 26 |
GO:0006418 | tRNA aminoacylation for protein translation | 7.73e-02 | 1.00e+00 | 3.641 | 1 | 4 | 29 |
GO:0008094 | DNA-dependent ATPase activity | 7.73e-02 | 1.00e+00 | 3.641 | 1 | 6 | 29 |
GO:0000737 | DNA catabolic process, endonucleolytic | 7.73e-02 | 1.00e+00 | 3.641 | 1 | 2 | 29 |
GO:0006446 | regulation of translational initiation | 7.73e-02 | 1.00e+00 | 3.641 | 1 | 2 | 29 |
GO:0045111 | intermediate filament cytoskeleton | 8.24e-02 | 1.00e+00 | 3.544 | 1 | 3 | 31 |
GO:0008015 | blood circulation | 8.24e-02 | 1.00e+00 | 3.544 | 1 | 1 | 31 |
GO:0005737 | cytoplasm | 8.46e-02 | 1.00e+00 | 0.595 | 11 | 127 | 2633 |
GO:0007077 | mitotic nuclear envelope disassembly | 8.49e-02 | 1.00e+00 | 3.499 | 1 | 9 | 32 |
GO:0015030 | Cajal body | 8.49e-02 | 1.00e+00 | 3.499 | 1 | 3 | 32 |
GO:0004842 | ubiquitin-protein transferase activity | 8.70e-02 | 1.00e+00 | 2.015 | 2 | 17 | 179 |
GO:0017148 | negative regulation of translation | 8.75e-02 | 1.00e+00 | 3.454 | 1 | 5 | 33 |
GO:0000786 | nucleosome | 9.00e-02 | 1.00e+00 | 3.411 | 1 | 2 | 34 |
GO:0071407 | cellular response to organic cyclic compound | 9.00e-02 | 1.00e+00 | 3.411 | 1 | 2 | 34 |
GO:0007254 | JNK cascade | 9.00e-02 | 1.00e+00 | 3.411 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 9.25e-02 | 1.00e+00 | 3.369 | 1 | 5 | 35 |
GO:0044297 | cell body | 9.25e-02 | 1.00e+00 | 3.369 | 1 | 5 | 35 |
GO:0005975 | carbohydrate metabolic process | 9.29e-02 | 1.00e+00 | 1.959 | 2 | 10 | 186 |
GO:0008645 | hexose transport | 9.50e-02 | 1.00e+00 | 3.329 | 1 | 8 | 36 |
GO:0005201 | extracellular matrix structural constituent | 9.75e-02 | 1.00e+00 | 3.289 | 1 | 1 | 37 |
GO:0003743 | translation initiation factor activity | 9.75e-02 | 1.00e+00 | 3.289 | 1 | 8 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.00e-01 | 1.00e+00 | 3.251 | 1 | 4 | 38 |
GO:0048511 | rhythmic process | 1.00e-01 | 1.00e+00 | 3.251 | 1 | 5 | 38 |
GO:0043202 | lysosomal lumen | 1.03e-01 | 1.00e+00 | 3.213 | 1 | 1 | 39 |
GO:0006396 | RNA processing | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 4 | 40 |
GO:0003684 | damaged DNA binding | 1.08e-01 | 1.00e+00 | 3.141 | 1 | 1 | 41 |
GO:0006281 | DNA repair | 1.08e-01 | 1.00e+00 | 1.833 | 2 | 24 | 203 |
GO:0008217 | regulation of blood pressure | 1.10e-01 | 1.00e+00 | 3.106 | 1 | 2 | 42 |
GO:0000724 | double-strand break repair via homologous recombination | 1.10e-01 | 1.00e+00 | 3.106 | 1 | 5 | 42 |
GO:0009612 | response to mechanical stimulus | 1.20e-01 | 1.00e+00 | 2.975 | 1 | 2 | 46 |
GO:0015758 | glucose transport | 1.25e-01 | 1.00e+00 | 2.914 | 1 | 8 | 48 |
GO:0006310 | DNA recombination | 1.30e-01 | 1.00e+00 | 2.855 | 1 | 8 | 50 |
GO:0005643 | nuclear pore | 1.32e-01 | 1.00e+00 | 2.826 | 1 | 12 | 51 |
GO:0005796 | Golgi lumen | 1.34e-01 | 1.00e+00 | 2.798 | 1 | 1 | 52 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.34e-01 | 1.00e+00 | 2.798 | 1 | 8 | 52 |
GO:0030203 | glycosaminoglycan metabolic process | 1.37e-01 | 1.00e+00 | 2.771 | 1 | 1 | 53 |
GO:0006338 | chromatin remodeling | 1.42e-01 | 1.00e+00 | 2.717 | 1 | 7 | 55 |
GO:0016311 | dephosphorylation | 1.42e-01 | 1.00e+00 | 2.717 | 1 | 3 | 55 |
GO:0008584 | male gonad development | 1.46e-01 | 1.00e+00 | 2.666 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 1.49e-01 | 1.00e+00 | 2.641 | 1 | 5 | 58 |
GO:0000785 | chromatin | 1.51e-01 | 1.00e+00 | 2.616 | 1 | 6 | 59 |
GO:0003682 | chromatin binding | 1.53e-01 | 1.00e+00 | 1.521 | 2 | 15 | 252 |
GO:0071013 | catalytic step 2 spliceosome | 1.56e-01 | 1.00e+00 | 2.568 | 1 | 5 | 61 |
GO:0006464 | cellular protein modification process | 1.56e-01 | 1.00e+00 | 2.568 | 1 | 4 | 61 |
GO:0006415 | translational termination | 1.61e-01 | 1.00e+00 | 2.521 | 1 | 2 | 63 |
GO:0030018 | Z disc | 1.63e-01 | 1.00e+00 | 2.499 | 1 | 3 | 64 |
GO:0006364 | rRNA processing | 1.70e-01 | 1.00e+00 | 2.432 | 1 | 2 | 67 |
GO:0030308 | negative regulation of cell growth | 1.77e-01 | 1.00e+00 | 2.369 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.77e-01 | 1.00e+00 | 2.369 | 1 | 5 | 70 |
GO:0071456 | cellular response to hypoxia | 1.90e-01 | 1.00e+00 | 2.251 | 1 | 2 | 76 |
GO:0001501 | skeletal system development | 2.04e-01 | 1.00e+00 | 2.141 | 1 | 2 | 82 |
GO:0005515 | protein binding | 2.06e-01 | 1.00e+00 | 0.296 | 14 | 198 | 4124 |
GO:0005635 | nuclear envelope | 2.06e-01 | 1.00e+00 | 2.123 | 1 | 6 | 83 |
GO:0005829 | cytosol | 2.12e-01 | 1.00e+00 | 0.503 | 7 | 88 | 1787 |
GO:0031982 | vesicle | 2.15e-01 | 1.00e+00 | 2.056 | 1 | 2 | 87 |
GO:0020037 | heme binding | 2.17e-01 | 1.00e+00 | 2.039 | 1 | 3 | 88 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.18e-01 | 1.00e+00 | 1.190 | 2 | 17 | 317 |
GO:0008201 | heparin binding | 2.24e-01 | 1.00e+00 | 1.991 | 1 | 4 | 91 |
GO:0000209 | protein polyubiquitination | 2.26e-01 | 1.00e+00 | 1.975 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 2.26e-01 | 1.00e+00 | 1.975 | 1 | 6 | 92 |
GO:0005524 | ATP binding | 2.29e-01 | 1.00e+00 | 0.698 | 4 | 37 | 892 |
GO:0006260 | DNA replication | 2.30e-01 | 1.00e+00 | 1.944 | 1 | 9 | 94 |
GO:0008017 | microtubule binding | 2.37e-01 | 1.00e+00 | 1.899 | 1 | 9 | 97 |
GO:0006457 | protein folding | 2.37e-01 | 1.00e+00 | 1.899 | 1 | 5 | 97 |
GO:0007596 | blood coagulation | 2.41e-01 | 1.00e+00 | 1.093 | 2 | 13 | 339 |
GO:0006413 | translational initiation | 2.41e-01 | 1.00e+00 | 1.869 | 1 | 6 | 99 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.43e-01 | 1.00e+00 | 1.085 | 2 | 23 | 341 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.53e-01 | 1.00e+00 | 1.784 | 1 | 5 | 105 |
GO:0044267 | cellular protein metabolic process | 2.54e-01 | 1.00e+00 | 1.039 | 2 | 14 | 352 |
GO:0046872 | metal ion binding | 2.55e-01 | 1.00e+00 | 0.631 | 4 | 24 | 934 |
GO:0031012 | extracellular matrix | 2.58e-01 | 1.00e+00 | 1.757 | 1 | 4 | 107 |
GO:0042981 | regulation of apoptotic process | 2.68e-01 | 1.00e+00 | 1.691 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 2.70e-01 | 1.00e+00 | 1.678 | 1 | 6 | 113 |
GO:0000287 | magnesium ion binding | 2.74e-01 | 1.00e+00 | 1.653 | 1 | 4 | 115 |
GO:0005578 | proteinaceous extracellular matrix | 2.74e-01 | 1.00e+00 | 1.653 | 1 | 4 | 115 |
GO:0004872 | receptor activity | 2.76e-01 | 1.00e+00 | 1.641 | 1 | 4 | 116 |
GO:0003924 | GTPase activity | 2.82e-01 | 1.00e+00 | 1.604 | 1 | 7 | 119 |
GO:0000082 | G1/S transition of mitotic cell cycle | 2.94e-01 | 1.00e+00 | 1.533 | 1 | 4 | 125 |
GO:0006184 | GTP catabolic process | 3.04e-01 | 1.00e+00 | 1.476 | 1 | 7 | 130 |
GO:0044212 | transcription regulatory region DNA binding | 3.29e-01 | 1.00e+00 | 1.339 | 1 | 13 | 143 |
GO:0001701 | in utero embryonic development | 3.49e-01 | 1.00e+00 | 1.232 | 1 | 7 | 154 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.62e-01 | 1.00e+00 | 0.666 | 2 | 29 | 456 |
GO:0005874 | microtubule | 3.66e-01 | 1.00e+00 | 1.150 | 1 | 10 | 163 |
GO:0007067 | mitotic nuclear division | 3.69e-01 | 1.00e+00 | 1.132 | 1 | 9 | 165 |
GO:0007283 | spermatogenesis | 3.74e-01 | 1.00e+00 | 1.106 | 1 | 4 | 168 |
GO:0016071 | mRNA metabolic process | 3.78e-01 | 1.00e+00 | 1.089 | 1 | 10 | 170 |
GO:0019221 | cytokine-mediated signaling pathway | 3.82e-01 | 1.00e+00 | 1.072 | 1 | 10 | 172 |
GO:0000166 | nucleotide binding | 3.88e-01 | 1.00e+00 | 1.039 | 1 | 13 | 176 |
GO:0006412 | translation | 3.92e-01 | 1.00e+00 | 1.023 | 1 | 12 | 178 |
GO:0008152 | metabolic process | 3.99e-01 | 1.00e+00 | 0.991 | 1 | 6 | 182 |
GO:0016567 | protein ubiquitination | 4.09e-01 | 1.00e+00 | 0.944 | 1 | 14 | 188 |
GO:0016070 | RNA metabolic process | 4.09e-01 | 1.00e+00 | 0.944 | 1 | 10 | 188 |
GO:0005856 | cytoskeleton | 4.12e-01 | 1.00e+00 | 0.929 | 1 | 8 | 190 |
GO:0044281 | small molecule metabolic process | 4.17e-01 | 1.00e+00 | 0.362 | 3 | 35 | 844 |
GO:0005743 | mitochondrial inner membrane | 4.24e-01 | 1.00e+00 | 0.876 | 1 | 9 | 197 |
GO:0030154 | cell differentiation | 4.35e-01 | 1.00e+00 | 0.826 | 1 | 5 | 204 |
GO:0005730 | nucleolus | 4.39e-01 | 1.00e+00 | 0.249 | 4 | 74 | 1217 |
GO:0019899 | enzyme binding | 4.44e-01 | 1.00e+00 | 0.784 | 1 | 7 | 210 |
GO:0007275 | multicellular organismal development | 4.51e-01 | 1.00e+00 | 0.757 | 1 | 9 | 214 |
GO:0006200 | ATP catabolic process | 4.58e-01 | 1.00e+00 | 0.724 | 1 | 13 | 219 |
GO:0006508 | proteolysis | 5.23e-01 | 1.00e+00 | 0.454 | 1 | 11 | 264 |
GO:0046982 | protein heterodimerization activity | 5.25e-01 | 1.00e+00 | 0.449 | 1 | 11 | 265 |
GO:0008285 | negative regulation of cell proliferation | 5.41e-01 | 1.00e+00 | 0.385 | 1 | 11 | 277 |
GO:0005634 | nucleus | 5.68e-01 | 1.00e+00 | 0.004 | 9 | 158 | 3246 |
GO:0006355 | regulation of transcription, DNA-templated | 5.98e-01 | 1.00e+00 | 0.017 | 2 | 31 | 715 |
GO:0055085 | transmembrane transport | 6.04e-01 | 1.00e+00 | 0.137 | 1 | 13 | 329 |
GO:0048471 | perinuclear region of cytoplasm | 6.21e-01 | 1.00e+00 | 0.072 | 1 | 11 | 344 |
GO:0005509 | calcium ion binding | 6.28e-01 | 1.00e+00 | 0.043 | 1 | 9 | 351 |
GO:0042802 | identical protein binding | 6.32e-01 | 1.00e+00 | 0.031 | 1 | 15 | 354 |
GO:0045893 | positive regulation of transcription, DNA-templated | 6.55e-01 | 1.00e+00 | -0.060 | 1 | 21 | 377 |
GO:0005783 | endoplasmic reticulum | 6.59e-01 | 1.00e+00 | -0.075 | 1 | 12 | 381 |
GO:0042803 | protein homodimerization activity | 7.02e-01 | 1.00e+00 | -0.243 | 1 | 13 | 428 |
GO:0003677 | DNA binding | 7.52e-01 | 1.00e+00 | -0.389 | 2 | 52 | 947 |
GO:0005887 | integral component of plasma membrane | 8.06e-01 | 1.00e+00 | -0.669 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 8.29e-01 | 1.00e+00 | -0.773 | 1 | 24 | 618 |
GO:0005576 | extracellular region | 8.51e-01 | 1.00e+00 | -0.874 | 1 | 15 | 663 |
GO:0070062 | extracellular vesicular exosome | 8.56e-01 | 1.00e+00 | -0.597 | 3 | 51 | 1641 |
GO:0016020 | membrane | 8.64e-01 | 1.00e+00 | -0.739 | 2 | 56 | 1207 |
GO:0008270 | zinc ion binding | 8.77e-01 | 1.00e+00 | -1.007 | 1 | 39 | 727 |
GO:0006351 | transcription, DNA-templated | 9.57e-01 | 1.00e+00 | -1.573 | 1 | 47 | 1076 |
GO:0016021 | integral component of membrane | 9.90e-01 | 1.00e+00 | -2.077 | 1 | 19 | 1526 |
GO:0005886 | plasma membrane | 9.96e-01 | 1.00e+00 | -2.302 | 1 | 46 | 1784 |